Life Science REIT (LON:LABS) Stock Price Down 4.9% – Here’s Why

Life Science REIT plc (LON:LABS)’s stock price fell 4.9% during mid-day trading on Monday . The stock traded as low as GBX 39 ($0.49) and last traded at GBX 39 ($0.49). 583,238 shares traded hands during mid-day trading, a decline of 43% from the average session volume of 1,031,143 shares. The stock had previously closed at GBX 41 ($0.52).

Analyst Ratings Changes

A number of research firms recently commented on LABS. Shore Capital reiterated a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th. Berenberg Bank restated a “buy” rating and set a GBX 57 ($0.72) target price on shares of Life Science REIT in a research report on Thursday, October 3rd. Finally, Jefferies Financial Group cut their price target on shares of Life Science REIT from GBX 45 ($0.57) to GBX 36 ($0.46) and set a “hold” rating on the stock in a research report on Friday, August 30th.

Life Science REIT Trading Down 4.9 %

The company has a market cap of £136.50 million, a price-to-earnings ratio of -650.00 and a beta of 0.08. The firm’s fifty day moving average price is GBX 38.37 and its 200-day moving average price is GBX 36.13.

Life Science REIT Dividend Announcement

The firm also recently declared a dividend, which was paid on Thursday, October 31st. Shareholders of record on Thursday, October 3rd were issued a GBX 1 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, October 3rd. This represents a dividend yield of 3.11%. Life Science REIT’s dividend payout ratio (DPR) is currently -3,333.33%.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.